ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
GeoVax Labs Inc

GeoVax Labs Inc (GOVX)

2.84
-0.29
(-9.27%)
Closed September 13 4:00PM
2.80
-0.04
(-1.41%)
After Hours: 7:59PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
2.80
Bid
2.77
Ask
2.82
Volume
1,422,196
2.7401 Day's Range 3.18
1.0901 52 Week Range 84.15
Market Cap
Previous Close
3.13
Open
3.10
Last Trade
78
@
2.8
Last Trade Time
Financial Volume
$ 4,115,191
VWAP
2.8935
Average Volume (3m)
3,510,942
Shares Outstanding
7,210,000
Dividend Yield
-
PE Ratio
-0.79
Earnings Per Share (EPS)
-3.6
Revenue
-
Net Profit
-25.97M

About GeoVax Labs Inc

Geovax Labs Inc is us-based clinical-stage biotechnology company. Geovax Labs Inc is us-based clinical-stage biotechnology company.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
GeoVax Labs Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GOVX. The last closing price for GeoVax Labs was $3.13. Over the last year, GeoVax Labs shares have traded in a share price range of $ 1.0901 to $ 84.15.

GeoVax Labs currently has 7,210,000 shares outstanding. The market capitalization of GeoVax Labs is $22.57 million. GeoVax Labs has a price to earnings ratio (PE ratio) of -0.79.

GOVX Latest News

GeoVax to Participate in Upcoming Investor Conferences in September

ATLANTA, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today...

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

ATLANTA, GA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious...

Registration is Now Open for Tribe Public’s Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Lab’s CEO

Company to Provide a Detailed Overview of Mpox Including Commentary on the Rapid Spread and Methods for Control, Treatment, and Prevention ATLANTA, GA, Aug. 21, 2024 (GLOBE NEWSWIRE) -- GeoVax...

GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market

ATLANTA, GA, Aug. 20, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.84-23.07692307693.6411.182.7401122939626.86137851CS
41.0963.74269005851.7111.181.668915185.39841625CS
120.7335.26570048312.0711.181.090135109425.00328476CS
26-5.9-67.8160919548.711.181.090118668805.06709978CS
52-69.05-96.102992345271.8584.151.0901367292827.54273943CS
156-42.2-93.777777777845130.651.0901316758133.46581937CS
2600003.94000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NOVVUNova Vision Acquisition Corporation
$ 41.00
(207.35%)
17.4k
NOVVNova Vision Acquisition Corporation
$ 37.0001
(200.08%)
205.22k
SMXSMX Security Matters Public Company
$ 5.85
(138.78%)
50.1M
OMICSingular Genomics Systems Inc
$ 12.38
(119.12%)
2.87M
TILInstill Bio Inc
$ 84.75
(82.41%)
3.91M
GSIWGarden Stage Ltd
$ 2.9693
(-75.66%)
4.24M
UPCUniverse Pharmaceuticals Inc
$ 0.55
(-67.07%)
30.45M
VMARVision Marine Technologies Inc
$ 0.77
(-48.67%)
34.54M
PRLDPrelude Therapeutics Inc
$ 2.775
(-42.55%)
2.49M
CNEYCN Energy Group Inc
$ 0.4335
(-37.17%)
5.06M
NVDANVIDIA Corporation
$ 119.10
(-0.03%)
225.83M
XXII22nd Century Group Inc
$ 0.3447
(28.00%)
168.56M
IMRXImmuneering Corporation
$ 2.02
(41.26%)
131.85M
SQQQProShares UltraPro Short QQQ
$ 8.17
(-1.33%)
122.46M
MULNMullen Automotive Inc
$ 0.1328
(-20.48%)
119.52M

GOVX Discussion

View Posts
tw0122 tw0122 5 hours ago
Mpox has spread to at least 14 African countries, including Morocco, which has confirmed its first case in the current outbreak. (Source: BBC Africa)
The Democratic Republic of Congo (DRC) is the epicenter of the outbreak, with over 20,000 cases reported and more than 500 deaths. (Source: WHO)
Neighboring countries, such as Burundi, Kenya, Rwanda, and Uganda, have also reported cases. (Source: WHO)
Vaccination Efforts

The World Health Organization (WHO) recommends use of MVA-BN or LC16 vaccines, or the ACAM2000 vaccine when others are not available. (Source: WHO)
Only people at risk of exposure to mpox should be considered for vaccination, according to WHO. (Source: WHO)
Transmission and Prevention

Mpox is primarily spread through close person-to-person contact with someone who is infected, including through sex. (Source: Nature)
Cleaning and disinfecting surfaces or objects and washing hands after touching contaminated surfaces or objects can help prevent transmission. (Source: WHO)
Avoiding unprotected contact with wild animals, especially those that are sick or dead, and cooking food thoroughly can reduce the risk of getting mpox from animals. (Source: WHO)
Public Health Emergency

The WHO declared the mpox outbreak a Public Health Emergency of International Concern (PHEIC) on August 19, 2024, citing the rapid spread of a new, more transmissible strain of the virus. (Source: WHO)
Research and Development

Scientists are racing to answer questions about the outbreak, including whether vaccines will curb the spread and how the virus is transmitted. (Source: Nature)
👍️0
tw0122 tw0122 5 hours ago
Looking good bottom about in for hedgies
👍️0
tw0122 tw0122 11 hours ago
Watch for 2.52 - .2.92 too hold for flip. 2.08- 2.20 next zone underneath if doesn’t
👍️0
tw0122 tw0122 11 hours ago
Hedgies determine new downtrend. New entry as we see $2.80s for another flip
👍️0
tw0122 tw0122 1 day ago
Ok hedgies confirming new upward trend perhaps give it a few hours still
👍️0
tw0122 tw0122 2 days ago
Flip the $3.06 at 3.30s and wait for hedgies to determine direction
👍️0
tw0122 tw0122 2 days ago
Tummies yummy $3.06 bought and then if happens to test next level down add again.
Hedgies want to take it as low as possible before the next big run into Covid vaccine season. Luv you Gary Gensler
👍️0
tw0122 tw0122 2 days ago
Good sign 3.06 hedgies covering shorts now volume picking up 600,000. Almost time to add some more goodies
👍️0
tw0122 tw0122 2 days ago
3.19 zone being tested if holds a few days start adding some again
👍️0
tw0122 tw0122 2 days ago
price of $5.125 per share for expected gross proceeds of $5 million.

4:39 AM EDT, 08/29/2024 (MT Newswires) -- GeoVax Labs (GOVX) said late Wednesday it has agreed to sell 975,610 common shares in a registered direct offering to an institutional investor at a price of $5.125 per share for expected gross proceeds of $5 million.

The company will also issue warrants to purchase up to 975,610 common shares to the investor in a concurrent private placement, it said. The warrants will be exercisable at a price of $5 per share.

Net proceeds will be used for working capital and general corporate purposes, the company said.

The offering is expected to close around Friday, sub
👍️0
tw0122 tw0122 3 days ago
Test 3.19- 3.55 zone wait to confirm before pulling trigger $2.52- 2.92 is the other zone. The hedgies that have most of the shares will determine that as they move this one as they please
👍️0
tw0122 tw0122 4 days ago
Covid flue season blooming still holding a few here but inclined to add some more ..

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines for many of the world’s most threatening infectious diseases and therapies for solid tumor cancers. The company’s lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine for which GeoVax was recently awarded a BARDA-funded contract to sponsor a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 versus an approved COVID-19 vaccine. In addition, GEO-CM04S1 is currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. The Company has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information about the current status of our clinical trials and other updates, visit our website: www.geovax.com.
👍️0
Gman3343 Gman3343 5 days ago
Going under 2.00 then time to buy.
👍️0
Monksdream Monksdream 2 weeks ago
GOVX under $5
👍️0
81vette 81vette 2 weeks ago
Warrents jumped up 100%
👍️0
Biggiee Biggiee 2 weeks ago
The Fauch knows how to party!
👍️0
Gman3343 Gman3343 3 weeks ago
Maybe the evil bastard will drop dead .
👍️0
tw0122 tw0122 3 weeks ago
Buy 6.30s sell $7.30s was todays lesson dip time coming again.. Dr. Fauci Somehow Contracts Ultra-Rare West Nile Virus On Heels Of COVID-19 Infection
👍️0
Gman3343 Gman3343 3 weeks ago
Good, keep giving that evil idiot all my vaccines and boosters.
He should double up
👍️0
tw0122 tw0122 3 weeks ago
Catch the dips play next.. Dr. Fauci has COVID again for the third time and has been vaccinated and boosted six times
👍️0
glenn1919 glenn1919 3 weeks ago
GOVX...............................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 3 weeks ago
sale of 1,700,000 shares of the Company’s common stock (or common stock equivalents) at a price of $5.00 per share in a registered direct offering priced above-the-market under Nasdaq rules.
In addition, in a concurrent private placement, the Company will issue to the investor warrants to purchase up to 1,700,000 shares of common stock. The warrants have an exercise price of $5.00 per share, will be exercisable immediately following the date of issuance and will have a term of five years from the date of issuance.
👍️0
ipo_dude ipo_dude 3 weeks ago
I wish ..
👍️0
rouge Vaughn rouge Vaughn 3 weeks ago
15 to 20 let's goooo
👍️0
tw0122 tw0122 3 weeks ago
Next stop $15 then $20…By Amanda Alvarado
Published: Aug. 21, 2024 at 8:02 AM EDT
(Gray News) - COVID-19 cases are rising and KP.3.1.1 is the predominant variant in the United States, according to the Centers for Disease Control and Prevention.

The variant accounted for between 31% and 43% of the cases in the two-week period ending on Aug. 17.

KP.3.1.1 is currently the only major variant increasing in proportion nationally, according to the CDC.

Emergency room visits diagnosed as COVID-19 started increasing in May in the West and are now the highest in the South and Southeast. The wastewater viral activity level for COVID-19 has been rising since mid-May and is currently very high across most parts of the country, according to the CDC.
👍️0
tw0122 tw0122 3 weeks ago
- Kamala Harris issues vaccine mandate for campaign workers..Good news for vaccine makers pump em up.
👍️0
tw0122 tw0122 3 weeks ago
Still have $1.80 shares left from a couple weeks back holding for the Gold longer term rest been cashed out
👍️ 1
glenn1919 glenn1919 3 weeks ago
GOVX....................................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783
👍️0
Backstabbed Backstabbed 4 weeks ago
Damn… nice play guys. Missed this one. I bought my first stock today in months!

Been terrible year
👍️0
81vette 81vette 4 weeks ago
Huge winner today,warrents was even better because of big spread, easy 15-19% wins
👍️0
gail gail 4 weeks ago
and back out before the dump, but it tried.
👍️0
gail gail 4 weeks ago
i grabbed some on the dip today.
👍️0
glenn1919 glenn1919 4 weeks ago
GOVX..................................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783
👍️0
ollik78 ollik78 4 weeks ago
Can we see 20$+ this week?
Yes we can 💲💲💲
👍️0
tw0122 tw0122 4 weeks ago
Cash out some more…Shares of mpox vaccine maker Bavarian Nordic saw an increase this week after the World Health Organization (WHO) declared a public health emergency and as the company’s CEO announced it could provide 10 million doses of the vaccine.

“We have inventory and we have the capabilities. What we’re missing are the orders,” CEO Paul Chaplin told Bloomberg this week.
👍️0
Monksdream Monksdream 4 weeks ago
Wowser what a reaction

https://ih.advfn.com/markets/nasdaq/premarket
👍️0
CarlCarlMcB CarlCarlMcB 4 weeks ago
Merry Christmas $$$$$$$$$$))))))))
👍️0
hinkydink hinkydink 4 weeks ago
So, what is the catalyst for this latest rise?
👍️0
Monksdream Monksdream 4 weeks ago
From my Morning Brew eltter
👍️0
Monksdream Monksdream 4 weeks ago
For the record GOVX did a 1 for 15 reverse split on JANUARY 31 2024
Could it go to $50 in the fullness of time
Government health officials are fearful about the continued spread as they with the spread of the flu eating cattle and milk cattle
👍️0
Monksdream Monksdream 4 weeks ago
Mpox is threatening to go global
Scientist in labNathan Posner/Getty Images
A more dangerous version of the virus formerly known as monkeypox spread outside of Africa for the first time this week, leading European officials to raise the Continent’s risk level from low to moderate.

ICYMI: The World Health Organization declared mpox a global health emergency on Wednesday, about two years after pulling the same alarm on a different variant that infected almost 100,000 people worldwide and 32,000+ in the US, according to the New York Times.

The new version is deadlier and spreading. On Thursday, Sweden reported that a traveler who returned from Africa contracted the variant, and yesterday, Pakistan reported its first case. In Africa, infections have sprung up in at least a dozen countries, in addition to the Democratic Republic of Congo, where 15,600 people caught the virus and 537 died from it this year, per the WHO.

The virus appears to spread through skin or fluid contact with another infected person or their items.

Vax news: Danish biotech firm Bavarian Nordic—the only company with an FDA-approved mpox vaccine—submitted data to EU regulators yesterday for approval to use its shot on teens, who account for more than 70% of the cases in Africa, Bavarian’s CEO told CNBC. The vax-maker says it has 300,000 doses ready to ship out and could deliver 10 million by the end of 2025. Its stock soared 50% this week.—ML
👍️0
declaes declaes 4 weeks ago
Indeed. But hope to reload soon. Great to make good money in this bear 🐻 market.

Hagwe
👍️0
Filterthenoise Filterthenoise 4 weeks ago
Beast mode $GOVX
👍️0
tw0122 tw0122 4 weeks ago
Excellent $8 definitely hardest resistance. Unloaded another batch but still holding some for the $20 could be a while dependent on Congo mpox
👍️0
declaes declaes 4 weeks ago
Sold at $8 from $2 nice money for the weekend 💰😍

Gltya... hope to see you all at $20 soon.

Next runner will be....
👍️0
tw0122 tw0122 4 weeks ago
7.98 halt
👍️0
tw0122 tw0122 4 weeks ago
$7.73 hod
👍️0
Penny chatter Penny chatter 4 weeks ago
This was expected Peter uterus
👍️0
it_happens it_happens 4 weeks ago
Fun to watch L2 today
👍️0
peterus peterus 4 weeks ago
lol why he making $$$$ ??????
👍️0

Your Recent History

Delayed Upgrade Clock